USD
$0.00
(0.00%
)At Close (As of Sep 8, 2025)
$1.74B
Market Cap
-
P/E Ratio
-0.18
EPS
$11.31
52 Week High
$6.01
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $438M |
Total Revenue | $451M |
Cost Of Revenue | $12M |
Costof Goods And Services Sold | $12M |
Operating Income | -$2.5M |
Selling General And Administrative | $266M |
Research And Development | $175M |
Operating Expenses | $441M |
Investment Income Net | - |
Net Interest Income | -$84M |
Interest Income | $15M |
Interest Expense | $99M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | -$87M |
Income Tax Expense | $1.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$89M |
Comprehensive Income Net Of Tax | - |
Ebit | $12M |
Ebitda | $13M |
Net Income | -$89M |
Field | Value (USD) |
---|---|
Total Assets | $490M |
Total Current Assets | $422M |
Cash And Cash Equivalents At Carrying Value | $105M |
Cash And Short Term Investments | $105M |
Inventory | $8.1M |
Current Net Receivables | $79M |
Total Non Current Assets | $68M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $20M |
Short Term Investments | $216M |
Other Current Assets | $14M |
Other Non Current Assets | - |
Total Liabilities | $966M |
Total Current Liabilities | $160M |
Current Accounts Payable | $12M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $35M |
Total Non Current Liabilities | $806M |
Capital Lease Obligations | $13M |
Long Term Debt | $796M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $841M |
Other Current Liabilities | $113M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$476M |
Treasury Stock | - |
Retained Earnings | -$1.8B |
Common Stock | $2.1M |
Common Stock Shares Outstanding | $207M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$52M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.2M |
Capital Expenditures | $1.1M |
Change In Receivables | - |
Change In Inventory | -$4.2M |
Profit Loss | - |
Cashflow From Investment | $53M |
Cashflow From Financing | -$5.8M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$89M |
Field | Value (USD) |
---|---|
Gross Profit | $438M |
Total Revenue | $451M |
Cost Of Revenue | $12M |
Costof Goods And Services Sold | $12M |
Operating Income | -$2.5M |
Selling General And Administrative | $266M |
Research And Development | $175M |
Operating Expenses | $441M |
Investment Income Net | - |
Net Interest Income | -$84M |
Interest Income | $15M |
Interest Expense | $99M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | -$87M |
Income Tax Expense | $1.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$89M |
Comprehensive Income Net Of Tax | - |
Ebit | $12M |
Ebitda | $13M |
Net Income | -$89M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.